Home | Business News | Browse by Publication | P | PR Newswire

Receptor BioLogix Acquires Late-Stage Cancer Drug from Aphton Corp.

Publication: PR Newswire
Publication Date: 31-JUL-06 		Format: Online
Delivery: Immediate Online Access

Article Excerpt
Insegia(TM) Immunotherapeutic for Pancreatic and Stomach Cancers

SOUTH SAN FRANCISCO, Calif., July 31 /PRNewswire/ -- Receptor BioLogix, Inc., a privately held biopharmaceutical company focused on development of cancer drugs, announced today that it has acquired the cancer vaccine Insegia(TM), and related assets, from Philadelphia-based Aphton Corp. (Pink Sheet: APHTQ) in a Chapter 11 bankruptcy sale that was recently approved by the U.S. Bankruptcy Court for the District of Delaware. The transaction is expected to close within 30 days, subject to certain conditions, including delivery of specified assets and related technology associated with Insegia. Financial details were not disclosed.

Insegia, also known as G17DT, is a therapeutic cancer vaccine that has been extensively studied for its effects...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from PR Newswire
Atlantis Holding Corp's President & CEO Discusses Company Plans in Int..., July 31, 2006
Halozyme Therapeutics Names Connie Matsui to Board of Directors., July 31, 2006
DreamFactory Announces Four Adaptive On-Demand Applications., July 31, 2006
MaXXan Achieves IBM System Storage Proven Designation., July 31, 2006
SAVE THE DATE: AIDS Healthcare Foundation Presents AfricAlive: Portrai..., July 31, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.